lifelong risk of cardiovascular disease. Descriptive statistics and odds ratios are presented. Logistic regression models estimated adjusted odds for receiving counseling adjusting for gestational age at diagnosis and severe features. RESULTS: Seventy-four women enrolled in the study, of which 70 (94.6%) returned for a postpartum visit. Median time to the postpartum visit was 5.0 weeks (IQR 4.4, 6.0). A hypertensive diagnosis was documented for 45 women (64.3%) at the postpartum visit, and only 11 (15.7%) received any counseling. Five women each were counseled on taking aspirin in a future pregnancy and follow-up with primary care. Only 3 (4.3%) were counseled on lifelong cardiovascular risk. Age, BMI, insurance status, having severe features, and taking prophylactic aspirin in the index pregnancy were not associated with receiving counseling. Only earlier gestational age at delivery was associated with counseling in adjusted analyses (adjusted OR 0.49, 95% CI 0.27-0.89). All 70 women had a contraceptive plan or discussion documented, including 26 (35.1%) who chose a LARC method. All four women with gestational diabetes were counseled on glucose tolerance testing. CONCLUSION: Counseling on lifelong cardiometabolic risk after HDP is not routine. Provider education is needed to improve patient communication of risk and facilitate timely follow-up.
RESULTS: Of the 3,761 women that met criteria for study entry, 134 were found to have chronic hypertension based on current guidelines (group 1), 327 had BP 130/80 mm Hg prior to 20 weeks gestation (group 2), and 3300 were normotensive controls (group 3). Women in groups 1 and 2 had similar demographic characteristics. (Table 1) . They were more likely to be older, have a higher prepregnancy BMI, and have pregestational diabetes. 25.4% of women in group 1 and 15% of women in group 2 developed preeclampsia as compared to 4.8% of controls (p<0.001). Women in group 2 were also more likely to develop gestational hypertension, gestational diabetes, deliver preterm, and undergo cesarean delivery than were controls. (Table 2) . CONCLUSION: Women with BP 130/80 mm Hg prior to 20 weeks gestation are at increased risk for developing hypertensive disorders of pregnancy. Additional analyses will clarify if blood pressure prior to 20 weeks gestation is an independent predictor of preeclampsia. Hypertension was defined as one value of systolic blood pressure greater than or equal to 140 or diastolic value greater than or equal to 90 during the time frame listed. Chi square was used to compare categorical variables and Student's t test for continuous. A logistic regression model was used to determine the odds of hypertension in the 2 years following delivery when subjects remained hypertensive in the 2-12 weeks postdelivery. Multivariable logistic regression analysis was used to adjust for confounding factors including maternal age, pre-pregnancy BMI, parity, smoking status, antepartum and intrapartum hypertension therapy, occurrence of pre-labor rupture of membranes, gestational age, and type of hypertension disorder. RESULTS: A cohort of 449 women was identified. Hypertension in the 2-12 weeks following delivery occurred in 86 (19%) of women. Hypertension at a visit between 2-12 weeks was associated with a 2.6-fold increased risk of continued hypertension in the 12 weeks to 24 months post-delivery (OR 2.65[1.6-4.3], p <0.001). In the adjusted analysis, hypertension had a 1.9-fold increased risk of having hypertension at 12 weeks to 24 months ], p¼0.027) after controlling for potential demographic and clinical confounders. CONCLUSION: Our data show that women who have hypertension noted between 2-12 weeks post-delivery have higher rates of continued hypertension up to 2 years from delivery. It is important to counsel these women on this risk at their postpartum follow up visits and encourage appropriate follow up with their primary care providers.
